Mead Johnson Nutrition Co. (NYSE:MJN)

CAPS Rating: 3 out of 5

Results 1 - 12 of 12

Recs

0
Member Avatar Dividends500 (71.57) Submitted: 3/26/2014 4:41:41 PM : Outperform Start Price: $76.71 MJN Score: +12.84

Dividends500 tracks the 200 strongest dividends in the S&P 500. To qualify as a strong dividend, the company must meet two simple requirements:

- A payout ratio below 50%
- An increasing dividend from the prior year

Because there are more than 200 dividend paying companies in the S&P 500 that meet these requirements, the qualifying companies with the largest dividend yields were chosen.

Dividends500 intends to test this FactSet article, which highlights these strong dividend paying companies and their outperformance versus the S&P 500 as a whole (Page 12).

http://www.factset.com/websitefiles/PDFs/dividend/dividend_12.16.13

If you have questions or see something you think is inaccurate feel free to let me know.

Recs

0
Member Avatar bladerunner (47.46) Submitted: 12/18/2013 4:21:31 PM : Outperform Start Price: $82.91 MJN Score: +4.20

Should benefit from the increase in newborns, ie in China and the laws/regulations are allowing only child parents to have an additional child.

Recs

0
Member Avatar stoney44 (< 20) Submitted: 11/1/2012 5:37:10 PM : Underperform Start Price: $61.89 MJN Score: -14.30

MJN has a weak marketing strategy and an innovation pipeline that is storng long trem but less so in 2013

Recs

0
Member Avatar chopchop0 (44.68) Submitted: 10/25/2012 10:31:16 AM : Outperform Start Price: $62.75 MJN Score: +10.14

Moaty brand and product

Recs

0
Member Avatar RugbyViking13 (91.62) Submitted: 7/12/2012 9:12:10 PM : Outperform Start Price: $74.90 MJN Score: -22.62

Nutricuticals, I believe is the buzz word

Recs

0
Member Avatar perspective03 (< 20) Submitted: 7/3/2011 10:20:51 AM : Underperform Start Price: $65.53 MJN Score: +4.54

They will underperform because competition will intensify and therefore Mead will need to increase their marketing efforts, this will increase costs. If they introduce a new formula that will allow a clear brand-differentitaiton, then they will have the opportunty to outperform. If not, then they will need to look to operations to reduce costs or expand to other markets in their goal to maintain their market share.

Recs

0
Member Avatar Pumpstick (99.31) Submitted: 8/12/2010 2:58:25 AM : Underperform Start Price: $47.34 MJN Score: -14.88

No!

Recs

0
Member Avatar gartersnk (51.13) Submitted: 12/2/2009 11:42:26 PM : Outperform Start Price: $39.43 MJN Score: +61.70

rocket since ipo

Recs

1
Member Avatar TheHague (52.34) Submitted: 7/26/2009 6:12:59 PM : Outperform Start Price: $33.93 MJN Score: +74.76

I have been with MJN almost since the beginning. Recently they have begun to pay dividends and appear to be very profitable and growing. Another nice defensive pick to keep the $'s coming in.

Recs

0
Member Avatar hopetrader (90.08) Submitted: 3/8/2009 1:11:11 AM : Outperform Start Price: $23.92 MJN Score: +97.77

Babies will keep being born. This is a great company. Once our economic conditions change and they get rid of the debt i see a huge turn around. Could drop down a little below IPO price but it will rise. Im long on this pick two years.

Recs

0
Member Avatar TMFBiologyFool (95.85) Submitted: 2/12/2009 2:31:39 PM : Underperform Start Price: $24.43 MJN Score: -139.71

A good move for BMY, but a little overpriced for now even if babies do have to eat during recessions.

Recs

0
Member Avatar XMFTom7 (74.12) Submitted: 2/12/2009 12:25:22 PM : Outperform Start Price: $24.75 MJN Score: +138.36

Babies gotta eat! ;)

Results 1 - 12 of 12

Featured Broker Partners


Advertisement